Healthcare provider profile · identity verified

Joshua Daniel Uy, MD

Geriatric Medicine · PHILADELPHIA, PA · NPI 1164422564

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	542	113
Amlodipine Besylate	Amlodipine Besylate	391	92
Eliquis	Apixaban	354	33
Metoprolol Succinate	Metoprolol Succinate	207	44
Gabapentin	Gabapentin	192	46
Losartan Potassium	Losartan Potassium	177	34
Mirtazapine	Mirtazapine	176	28
Furosemide	Furosemide	165	36
Clopidogrel	Clopidogrel Bisulfate	139	28
Lisinopril	Lisinopril	139	31
Carvedilol	Carvedilol	121	30
Metformin Hcl	Metformin Hcl	121	27
Sertraline Hcl	Sertraline Hcl	116	18
Tamsulosin Hcl	Tamsulosin Hcl	99	22
Trazodone Hcl	Trazodone Hcl	96	18
Hydrochlorothiazide	Hydrochlorothiazide	93	25
Nifedipine Er	Nifedipine	92	17
Levetiracetam	Levetiracetam	91	11
Levothyroxine Sodium	Levothyroxine Sodium	90	24
Rosuvastatin Calcium	Rosuvastatin Calcium	82	19
Allopurinol	Allopurinol	76	19
Omeprazole	Omeprazole	76	25
Hydralazine Hcl	Hydralazine Hcl	71	12
Escitalopram Oxalate	Escitalopram Oxalate	70	15
Oxycodone Hcl	Oxycodone Hcl	70	19
Januvia	Sitagliptin Phosphate	66	suppressed
Fluticasone Propionate	Fluticasone Propionate	65	25
Duloxetine Hcl	Duloxetine Hcl	64	14
Simvastatin	Simvastatin	58	15
Lorazepam	Lorazepam	57	suppressed
Lansoprazole	Lansoprazole	56	14
Buspirone Hcl	Buspirone Hcl	55	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	53	17
Quetiapine Fumarate	Quetiapine Fumarate	53	12
Fluoxetine Hcl	Fluoxetine Hcl	51	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	47	suppressed
Donepezil Hcl	Donepezil Hcl	47	13
Ezetimibe	Ezetimibe	46	suppressed
Latanoprost	Latanoprost	46	12
Pravastatin Sodium	Pravastatin Sodium	46	12
Albuterol Sulfate Hfa	Albuterol Sulfate	45	20
Breo Ellipta	Fluticasone/Vilanterol	45	suppressed
Metformin Hcl Er	Metformin Hcl	43	suppressed
Albuterol Sulfate	Albuterol Sulfate	42	suppressed
Famotidine	Famotidine	42	16
Jardiance	Empagliflozin	41	suppressed
Potassium Chloride	Potassium Chloride	41	13
Midodrine Hcl	Midodrine Hcl	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Risperidone	Risperidone	38	suppressed
Benztropine Mesylate	Benztropine Mesylate	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Valsartan	Valsartan	35	12
Prednisone	Prednisone	34	suppressed
Creon	Lipase/Protease/Amylase	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	12
Bumetanide	Bumetanide	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	31	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Baclofen	Baclofen	29	suppressed
Glipizide	Glipizide	29	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	29	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Atenolol	Atenolol	25	suppressed
Ketoconazole	Ketoconazole	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Anastrozole	Anastrozole	24	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	16
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Lovastatin	Lovastatin	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Repaglinide	Repaglinide	21	suppressed
Vascepa	Icosapent Ethyl	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	20	20
Azithromycin	Azithromycin	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Lyumjev	Insulin Lispro-Aabc	16	suppressed
Insulin Aspart Flexpen	Insulin Aspart	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Nyamyc	Nystatin	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Metformin Er Gastric	Metformin Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Acetazolamide	Acetazolamide	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Finasteride	Finasteride	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Renvela	Sevelamer Carbonate	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	12	suppressed
Torsemide	Torsemide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error